ArticleDiabetology & metabolic syndrome2017

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

Andre Gustavo Daher Vianna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.